Although gene alteration in KEAP1 or NFE2L2, encoding NRF2, are found in approximately 4 % of all cancer samples according to the cBioportal database, tumors harboring KEAP1 or NRF2 mutations are particularly higher in lung cancer (15 % or 9 %, respectively). Here, KEAP1 is linked to lung carcinoma.